Ahmed Kotb/daiichisankyo.us
Jul 18, 2026, 20:15
Ahmed Kotb: Exploring Qualitative Platelet Defects
Ahmed Kotb, Head of Global Oncology Medical Affairs at Daiichi Sankyo, shared a post on X:
“Qualitative Platelet Defects
Inherited
- Glanzmann: low GPIIb/IIIa – No aggregation except ristocetin
- Bernard–Soulier: low GPIb – Abnormal ristocetin
- Storage pool disease: Absent 2ry wave
Acquired
- Drugs:Aspirin, Clopidogrel, GP IIb/IIIa inhibitor
- Diseases: Uremia, liver disease”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 03:07Luke McLaughlin: The First Community Article of the Haemophilia Rights Project
-
Sep 5, 2026, 03:00Panagiotis Christoforou: Proud to Contribute to Barts Health’s Leading Role in UK Clinical Trials
-
Sep 5, 2026, 02:51Kassiani Maria Nastouli: Honored to Be Cited in the New ESC Guidelines on the Management of CVD and CKD
-
Sep 5, 2026, 02:44Sedat Gül: Is It Time to Reconsider the 24-Hour Antiplatelet Delay After Thrombolysis?
-
Sep 5, 2026, 02:35Balaji Balagani: Exploring Stable vs Unstable vs Complete Coronary Block
-
Sep 5, 2026, 02:28N. Mariana S. Vasquez: Warm vs Cold Autoimmune Hemolytic Anemia for USMLE/NBME Questions
-
Sep 4, 2026, 22:03Maeve Crowley: Haemophilia Treatment Over the Decades and Hope for the Future
-
Sep 4, 2026, 22:01Lama Skieker: Understanding Thrombocytopenia in Malaria
-
Sep 4, 2026, 22:00Hiten Patel: How an IVC Filter Helps Prevent Pulmonary Embolism